Biomarkers of Periodontal Disease Progression

CompletedOBSERVATIONAL
Enrollment

157

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2016

Study Completion Date

May 31, 2017

Conditions
Periodontal Disease
Interventions
OTHER

Periodontal therapy

All subjects will have professional dental prophylaxis and periodontal therapy withheld for 12 months during the disease progression and monitoring phase. After 12 months, subjects with periodontal disease will receive periodontal therapy to consist of scaling and root planing, and periodontally healthy subjects will receive professional dental prophylaxis. Subjects with periodontal disease will also receive Supportive Periodontal Therapy at the 3- and 6-month post-therapy visits. Subjects showing periodontal disease progression greater than a predetermined threshold during the monitoring or maintenance phases of the study will be given rescue therapy consisting of placement of a local antibiotic at the site of disease progression.

Trial Locations (5)

10010

NYU College of Dentistry, New York

14228

State University of New York at Buffalo, Buffalo

48109

University of Michigan School of Dentistry, Ann Arbor

62026

Southern Illinois University, Edwardsville

02142

The Forsyth Institute, Cambridge

All Listed Sponsors
collaborator

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

collaborator

NYU Langone Health

OTHER

collaborator

State University of New York at Buffalo

OTHER

collaborator

University of Michigan

OTHER

collaborator

Southern Illinois University

OTHER

lead

The Forsyth Institute

OTHER

NCT01489839 - Biomarkers of Periodontal Disease Progression | Biotech Hunter | Biotech Hunter